AnovaOS Network Powered Patient Registry

RecruitingOBSERVATIONAL
Enrollment

100,000

Participants

Timeline

Start Date

September 1, 2021

Primary Completion Date

August 31, 2025

Study Completion Date

August 31, 2026

Conditions
Infectious DiseaseNeoplasmsDiseases of the Blood and Blood-Forming Organs and Certain Disorders Involving the Immune Mechanism (D50-D89)Endocrine, Nutritional and Metabolic Diseases (E00-E89)Mental and Behavioural DisordersDiseases of the Nervous SystemDiseases of the Eye and AdnexaDiseases of the Ear and Mastoid ProcessDiseases of the Circulatory SystemDiseases of the Respiratory SystemDiseases of the Digestive SystemDiseases of the Skin and Subcutaneous TissueDiseases of the Musculoskeletal System and Connective TissueDiseases of the Genitourinary SystemPregnancy, Childbirth and the PuerperiumCertain Conditions Originating in the Perinatal PeriodCongenital Malformations, Deformations and Chromosomal Abnormalities (Q00-Q99)Symptoms, Signs and Abnormal Clinical and Laboratory Findings, Not Elsewhere ClassifiedInjury, Poisoning and Certain Other Consequences of External CausesExternal Causes of Morbidity and MortalityFactors Influencing Health Status and Contact With Health Services
Trial Locations (1)

60005

RECRUITING

Anova Enterprises, Inc., Arlington Heights

All Listed Sponsors
lead

Anova Enterprises, Inc

INDUSTRY